ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,332, issued on Nov. 18.
"Modified peptides and associated methods of use" was invented by Effat S. Emamian (Short Hills, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a modified peptide including (i) an amino acid sequence (X)-GRT-(Y)-TLC-(Z), or (ii) an amino acid sequence having at least 40% sequence identity to the amino acid sequence (X)-GRT-(Y)-TLC-(Z), wherein X, Y, and Z are the same as described in the specification. In this regard, methods for inhibiting the activity of at least one enzyme selected from the group consisting of AKT1 (PKB alpha), AKT2 (PKB beta), MAP3K8 (COT), MST4, AURKB (Aurora B), RO...